Three enigmatic BioH isoenzymes are programmed in the early stage of mycobacterial biotin synthesis, an attractive anti-TB drug target
Yongchang Xu,Jie Yang,Weihui Li,Shuaijie Song,Yu Shi,Lihan Wu,Jingdu Sun,Mengyun Hou,Jinzi Wang,Xu Jia,Huimin Zhang,Man Huang,Ting Lu,Jianhua Gan,Youjun Feng
DOI: https://doi.org/10.1371/journal.ppat.1010615
IF: 7.464
2022-07-12
PLoS Pathogens
Abstract:Tuberculosis (TB) is one of the leading infectious diseases of global concern, and one quarter of the world's population are TB carriers. Biotin metabolism appears to be an attractive anti-TB drug target. However, the first-stage of mycobacterial biotin synthesis is fragmentarily understood. Here we report that three evolutionarily-distinct BioH isoenzymes (BioH1 to BioH3) are programmed in biotin synthesis of Mycobacterium smegmatis . Expression of an individual bioH isoform is sufficient to allow the growth of an Escherichia coli Δ bioH mutant on the non-permissive condition lacking biotin. The enzymatic activity in vitro combined with biotin bioassay in vivo reveals that BioH2 and BioH3 are capable of removing methyl moiety from pimeloyl-ACP methyl ester to give pimeloyl-ACP, a cognate precursor for biotin synthesis. In particular, we determine the crystal structure of dimeric BioH3 at 2.27Å, featuring a unique lid domain. Apart from its catalytic triad, we also dissect the substrate recognition of BioH3 by pimeloyl-ACP methyl ester. The removal of triple bioH isoforms (Δ bioH1 / 2 / 3 ) renders M . smegmatis biotin auxotrophic. Along with the newly-identified Tam/BioC, the discovery of three unusual BioH isoforms defines an atypical 'BioC-BioH(3)' paradigm for the first-stage of mycobacterial biotin synthesis. This study solves a long-standing puzzle in mycobacterial nutritional immunity, providing an alternative anti-TB drug target. Biotin (vitamin B7) is essential for nutritional immunity in TB-causing bacterium, M . tuberculosis . Here, we show that three distinct BioH isoforms (BioH1 to BioH3) are programmed in the first-stage of mycobacterial biotin synthesis, a validated anti-TB drug target. BioH2 and BioH3 are active in the hydrolysis of M-C7-ACP to give C7-ACP, a bona fide precursor of the late step of biotin synthesis. The 2.27Å x-ray structure of BioH3 dimer allows us to illustrate its catalysis mechanism. The triple mutant of Δ bioH1 / 2 / 3 is biotin auxotrophic. The two biochemically-amenable enzymes BioH2 and BioH3 enables the in vitro reconstitution of biotin synthesis. Combined with the recently-identified Tam/BioC, characterization of three mysterious BioH isoenzymes defines an atypical paradigm of 'BioC-BioH(3)' for the early step of mycobacterial biotin synthesis.
microbiology,virology,parasitology